Even with an increasing number of employers calling their workers back into the office following the pandemic, many employees across the United States are still working from home or otherwise working remotely. While many employers tout the flexibility of work-from-home as a benefit for employees, managing a remote workforce can raise a number of multistate compliance challenges. In particular, remote and hybrid work has significant implications for employers’ state and local tax withholding and unemployment insurance contribution obligations. Planning...

Read more

The Federal Trade Commission (FTC) continues to issue guidance on the use of generative artificial intelligence (AI) and the potential regulatory scrutiny facing companies and creators using these new tools in the market. While the FTC has previously addressed issues such as exaggerating the use of AI in a product or the potential deceptiveness related to deepfakes or synthetic media, the most recent guidance focused on the impact of the use of generative AI in the creation of content and related digital products arising...

Read more

The Federal Trade Commission (FTC) and Department of Justice (DOJ), Antitrust Division announced that they will hold three workshops regarding their jointly issued Draft Merger Guidelines. The first virtual workshop will be held on September 5, at 1-4:15 p.m. ET. The agencies released the Draft Merger Guidelines for public comment on July 19. The draft sets forth the following 13 broad guidelines: Mergers should not significantly increase concentration in highly concentrated markets. Mergers should not eliminate substantial competition between firms. Mergers...

Read more

Research and development (R&D) collaborations present a win-win opportunity for big pharma and their biotech partners. Pharma companies can use collaborations to  supplement their R&D pipelines without the large cash outlays necessitated by acquisitions. By spreading available cash across multiple collaborations, they increase their “shots on goal” of finding the next blockbuster drug/therapy. Similarly, collaborations are attractive to smaller specialty pharma and biotech companies looking to partner certain noncore assets as a source of nondilutive financing or to accelerate life-saving...

Read more

On August 29, 2023, the California Privacy Protection Agency (CPPA) posted discussion drafts of its forthcoming regulations on cybersecurity audits and risk assessments as part of the materials for its September 8, 2023, public board meeting. These draft regulations are expected to eventually become part of the CPPA’s second rulemaking package under the California Consumer Privacy Act (CCPA) since the CCPA’s amendment by the California Privacy Rights Act. The CPPA has not yet started its formal rulemaking process for...

Read more

With the help of our members, this thought-leadership series explores the acceleration of “digitalization” on both sides of the Atlantic, and across various industries. Today, we present, Ana Razmazma, Counsel, at FENWICK & WEST in Silicon Valley, CA; along with Katie Hewson, Partner, and Daniel Jones, Associate both at STEPHENSON HARWOOD in London, UK. They will address: “AI Regulation – Latest Legal Developments in Europe and the US”.  Navigating the Landscape of AI Regulation on Both Sides of the Pond:...

Read more